Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

SHE/300832 stock hub

SHE/300832 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300832is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

37.3B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300832

In the news

Latest news · SHE/300832

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E20

P25 17.1P50 24.2P75 37.8

Trailing P/E22.9

P25 23.5P50 41.3P75 83.2

ROE17.6

P25 -0.9P50 4.1P75 8.8

ROIC24.6

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300832 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

234

Groups with data

Currency

CNY

Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	2,785
Employees Change	-56%
Employees Change Percent	-1.97
Enterprise value	CNY 34.8B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Medical Devices
Isin	CNE100003T39
Last refreshed	2026-05-10
Market cap	CNY 37.3B
Price	CNY 47.43
Price currency	CNY
Rev Per Employee	1,644,734.2x
Sector	Healthcare
Sic	2835
Symbol	she/300832
Website	https://www.snibe.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.36%
EV Earnings	21.45x
EV/EBIT	19.17x
EV/EBITDA	17.28x
EV/FCF	22.93x
EV/Sales	7.61x
FCF yield	4.08%
Forward P/E	19.95x
P/B ratio	3.93x
P/E ratio	22.94x
P/S ratio	8.14x
PE Ratio3 Y	29.89x
PE Ratio5 Y	31.76x
PEG ratio	1.37x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	39.69%
EBITDA Margin	43.93%
FCF margin	33.18%
Gross margin	70.6%
Gross Profit	CNY 3.2B
Gross Profit Growth	-1.4%
Gross Profit Growth Q	8.4%
Gross Profit Growth3 Y	13.59%
Gross Profit Growth5 Y	11.59%
Net Income	CNY 1.6B
Net Income Growth	-11.69%
Net Income Growth Q	1.02%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	5.73%
Net Income Growth5 Y	10.27%
Pretax Margin	40.78%
Profit Margin	35.47%
Profit Per Employee	CNY 583,387
Profitable Years	14
ROA	11.39
Roa5y	12.67
ROCE	18.84
ROE	17.57
Roe5y	21.1
ROIC	24.56
Roic5y	39.59

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-7.16%
Cagr3y	-2.33%
Cagr5y	-4.63%
Div CAGR3	29.4%
EPS Growth	-11.69
EPS Growth Q	1.02
EPS Growth Years	0
EPS Growth3 Y	5.75
EPS Growth5 Y	9.83
FCF Growth	101.73%
FCF Growth3 Y	40.23%
FCF Growth5 Y	13.45%
OCF Growth	67.33%
OCF Growth Q	1,835.9%
OCF Growth10 Y	29.7%
OCF Growth3 Y	24.67%
OCF Growth5 Y	11.75%
Revenue Growth	-1.25x
Revenue Growth Q	0.34x
Revenue Growth Quarters	3x
Revenue Growth Years	13x
Revenue Growth3 Y	12.94x
Revenue Growth5 Y	13.44x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.46
Assets	CNY 10.2B
Cash	CNY 2.4B
Current Assets	CNY 6B
Current Liabilities	CNY 568.1M
Debt	CNY 3.7M
Debt EBITDA	CNY 0
Debt Equity	CNY 0
Debt FCF	CNY 0
Equity	CNY 9.5B
Interest Coverage	3,652.7
Liabilities	CNY 729.5M
Long Term Assets	CNY 4.2B
Long Term Liabilities	CNY 161.4M
Net Cash	CNY 2.4B
Net Cash By Market Cap	CNY 6.49
Net Cash Growth	-2.21%
Net Debt EBITDA	CNY -1.2
Net Debt Equity	CNY -0.26
Net Debt FCF	CNY -1.59
Tangible Book Value	CNY 9.3B
Tangible Book Value Per Share	CNY 11.78
WACC	3.02

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.54
Inventory Turnover	1.23
Net Working Capital	CNY 3B
Quick ratio	6.06
Working Capital	CNY 5.4B
Working Capital Turnover	CNY 0.93

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0%
Dividend Growth	30%
Dividend Growth Years	3%
Dividend per share	CNY 1.2
Dividend Years	6
Dividend Yield	2.53%
Ex Div Date	2025-05-28
Last Dividend	CNY 1.3
Payout Frequency	Annual
Payout Ratio	62.89%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-7.16%
200-day SMA	57.25
3Y total return	-6.83%
50-day SMA	49.31
50-day SMA vs 200-day SMA	50under200
5Y total return	-21.1%
All Time High	107.4
All Time High Change	-55.84%
All Time High Date	2020-10-15
All Time Low	19.83
All Time Low Change	139.23%
All Time Low Date	2020-05-12
ATR	1.65
Beta	-0.22
Beta1y	-0.01
Beta2y	0.2
Ch YTD	-15.68
High	48.4
High52	71.51
High52 Date	2025-09-12
High52ch	-33.67%
Low	47.01
Low52	43.85
Low52 Date	2026-04-14
Low52ch	8.16%
Ma50ch	-3.82%
Price vs 200-day SMA	-17.15%
RSI	48.32
RSI Monthly	40.13
RSI Weekly	35.9
Sharpe ratio	-0.16x
Sortino ratio	-0.04
Total Return	2.53%
Tr YTD	-15.68
Tr1m	1.61%
Tr1w	0.89%
Tr3m	-12.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 1.8B
Operating Income Growth	-6.56
Operating Income Growth Q	9.54
Operating Income Growth3 Y	9.92
Operating Income Growth5 Y	10.61
Operating margin	39.69

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	335,311,490%
Net Borrowing	-4,612,554
Shares Insiders	20.59%
Shares Institutions	16.17%
Shares Out	785,718,785
Shares Qo Q	-0%
Shares Yo Y	-0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 1.5B
Average Volume	5,859,326.95x
Bv Per Share	12.07
CAPEX	CNY -342.8M
Ch1m	1.61
Ch1w	0.89
Ch1y	-9.22
Ch3m	-12.33
Ch3y	-11.18
Ch5y	-26.43
Ch6m	-23.92
Change	0.49%
Change From Open	0.49
Close	47.2
Days Gap	0
Depreciation Amortization	194,137,075
Dollar Volume	228,200,575.6
Earnings Date	2026-04-28
EBIT	CNY 1.8B
EBITDA	CNY 2B
EPS	CNY 2.07
F Score	5
FCF	CNY 1.5B
FCF EV Yield	4.36x
FCF Per Share	CNY 1.93
Financing CF	-1,126,068,735
Fiscal Year End	December
Founded	1,995
Graham Number	23.7005
Graham Upside	-50.03
Income Tax	CNY 243.1M
Investing CF	144,950,748
Is Primary Listing	1
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Last Split Date	2021-05-21
Last Split Type	Forward
Lynch Fair Value	CNY 21.24
Lynch Upside	-55.23
Ma150	56.61
Ma150ch	-16.22%
Ma20	46.75
Ma20ch	1.45%
Net CF	832,349,484
Next Earnings Date	2026-08-28
Open	47.2
P FCF Ratio	24.52
P OCF Ratio	20.01
Payment Date	2025-05-28
Position In Range	30.22
Ppne	1,751,504,435
Price Date	2026-05-08
Price EBITDA	CNY 18.52
Ptbv Ratio	4.03
Relative Volume	0.85x
Revenue	4,580,584,760x
Tax By Revenue	5.31x
Tax Rate	13.01%
Tr6m	-23.92%
Volume	4,811,313
Z Score	40.16

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/300832 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.5%

$1.20 annual per share

Payout ratio

+62.9%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

3 consecutive years of growth

Total shareholder yield

+2.5%

Next ex-dividend date: 2025-05-28

Performance

SHE/300832 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300832?

Insider, institutional, and short-interest positioning.

Institutional ownership

+16.2%

Share of float held by funds and institutions

Insider ownership

+20.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

SHE/300832 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.3

Neutral momentum band

Price vs 200-day MA

-17.1%

50/200-day relationship not available

Beta (5Y)

-0.22

Less volatile than the market

Sharpe ratio

-0.16

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300832

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300832 stock rating?

she/300832 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300832 analysis?

The full report lives at /stocks/she/300832/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300832?

The latest report frames she/300832 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300832 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.